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Abstract 1 
The aims of the current study were to: a) investigate the reported prevalence of nutritional, 2 
medicinal, and performance enhancing substance use in dance, including any gender or 3 
professional status differences, and b) examine the amount of importance dancers place on 4 
potential sources of information regarding supplementation.  Methods involved administering 5 
an anonymous survey to 371 male (n = 83) and female (n = 286) UK-based dancers (Mage = 6 
20.87 years).  Use of at least one supplement was reported by 91.9% of the dancers surveyed, 7 
and prevalence rates were highest for multivitamins, over-the-counter painkillers, and high 8 
energy drinks.  Prevalence of use varied from low to high for specific nutritional and 9 
medicinal supplements, whereas very low levels of supplementation were seen for all 10 
performance enhancing supplements.  Numerous forms of supplementation were more 11 
prevalent in male and professional dancers in comparison to female and amateur dancers, 12 
respectively.  Across all categories of supplementation, physiotherapists and GPs/physicians 13 
were considered to be important sources of information on supplementation, whereas non-14 
dance friends were considered to be the least important source of information.  In conclusion, 15 
the current study provides much needed information on nutritional, medicinal and 16 
performance enhancing supplementation in dancers, and identifies key sources of information 17 
for dancers on all forms of supplementation. 18 
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Introduction 1 
Research in the athletic domain suggests athletes often look to support and facilitate 2 
their training and performance using a variety of nutritional, medicinal, and performance 3 
enhancing substances (e.g., de Hon, Kuipers, & van Bottenburg, 2015; Lazic et al., 2011).  4 
Regarding nutritional and medicinal substances, polypharmacy – or the inappropriate and 5 
excessive use of nutritional and medicinal substances (see Baylis, Cameron-Smith, & Burke, 6 
2011) has been linked with an increased likelihood of potentially serious health consequences 7 
(e.g., Chen, Biller, Willing, & Lopez, 2004; Palmer et al., 2003; Yetley, 2007).  Similarly, 8 
use of performance enhancing substances has also been associated with negative health 9 
consequences (Casavant, Blake, Griffith, Yates, & Copley, 2007).  Although prevalence of 10 
and information sources for nutritional supplement use has started to be investigated in dance 11 
populations (Brown & Wyon, 2014), very little is known regarding the use of medicinal and 12 
performance enhancing substances in this group, nor what information sources inform any 13 
use (see Sekulic, Peric, & Rodek, 2010).  As such, the overarching aim of the current study 14 
was to investigate the prevalence of nutritional, medicinal, and performance enhancing 15 
substance use in dancers, as well as the importance placed on a range of potential information 16 
sources regarding use of these substances. 17 
As alluded to above, it is possible to categorise substances taken to facilitate athletic 18 
performance into three broad categories: nutritional, medicinal and performance enhancing 19 
substances.  Nutritional – or dietary – substances have been defined as orally consumed 20 
products taken for the purpose of supplementing one’s normal diet and include substances 21 
such as vitamins, minerals, macronutrients (e.g., carbohydrate and protein supplements) and 22 
creatine monohydrate (U.S. Food and Drug Administration, 1994).  In contrast, medicinal 23 
substances are defined as drugs or other preparations designed to prevent or treat disease 24 
(Oxford Dictionary, 2015) with a drug being defined as a chemical substance that through 25 
interaction with biological target/s can alter the body’s biochemical systems and examples are 26 
painkillers, diuretics and decongestants (Mottram & Chester, 2015).  Finally, performance 27 
enhancing substances are those that appear on the World Anti-Doping Agency (WADA) list 28 
of substances prohibited for use in sport (Mottram & Chester, 2015) and include substances 29 
such as ephedrine stimulants, oral and injectable anabolic androgenic steroids, and beta-30 
blockers (WADA, 2015). 31 
When considering prevalence of use for nutritional, medicinal and performance 32 
enhancing substances, availability is an important consideration.  Although health (e.g., 33 
Casavant et al., 2007), moral (Erickson, McKenna, & Backhouse, 2015), and legal (Boardley 34 
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& Grix, 2014) issues may potentially influence decisions regarding supplementation, ease of 1 
availability may also influence prevalence of use.  As well as being easier to access, 2 
substances that are freely available may have an increased prevalence not just because they 3 
are easier to access, but because such availability may lead potential users to think they are 4 
safe to use.  Availability is of particular relevance to medicinal supplements, as some are 5 
freely available (i.e., over-the-counter [OTC] medicines), whereas others require certification 6 
via a medical professional (i.e., prescription medicines; Petróczi & Naughton, 2009).  7 
Performance enhancing substances are also likely to be more difficult to obtain than 8 
nutritional supplements or OTC medicines.  As such, availability may be an important 9 
consideration when considering prevalence of use for nutritional, medicinal and performance 10 
enhancing substances. 11 
Research to date has highlighted the importance of determining prevalence of use for 12 
nutritional supplements in athletic domains.  In the realm of sport, athletes from a variety of 13 
sports have reported rates of nutritional supplement use ranging from 32 to 90% (Baylis et 14 
al., 2001; Giannopoulou, Noutsos, Apostolidis, Bayios, & Nassis, 2013; Lazic et al., 2011; 15 
Ronsen, Sundgot-Borgen, & Maehlum, 1999; Schroder, Navarro, Mora, Seco, Torregrosa, 16 
&Tramullas, 2002; Sundgot-Borgen, Berglund, & Torstveit, 2003).  Such prevalence rates are 17 
important because research has shown more than 10% of freely available nutritional 18 
supplements may be contaminated with performance enhancing substances such as stimulants 19 
and anabolic steroids (Baume, Mahler, Kamber, Mangin, Saugy, 2006; Geyer, Parr, Koehler, 20 
Mareck, Schanzer, & Thevis, 2008; Geyer, Parr, Mareck, Reinhart, Schrader, & Schanzer, 21 
2004).  As such, those who take nutritional substances may risk inadvertently taking 22 
substances they had not intended to. 23 
As well as the potential for inadvertently taking unintended substances, it is also 24 
important to determine use of nutritional supplements due to the suggestion that such use may 25 
sometimes act as a gateway to use of prohibited substances.  For instance, Boardley and Grix 26 
(2014) and Martinez and Bilard (2003) have both described processes based upon athlete 27 
accounts whereby initial use of legal nutritional substances may lead to use of prohibited 28 
substances for some athletes.  Support for such a process is seen in research that has shown 29 
that nutritional supplement users are more likely to be prohibited substance users and also 30 
have different attitudes toward doping in comparison to non-users of nutritional supplements 31 
(Backhouse, Whitaker, & Petróczi, 2013; Mazanov, Petroczi, Bingham, & Holloway, 2008; 32 
Papadopoulos, Skalkidis, Parkkari, & Petridou, 2006). As such, it is also important to 33 
understand prevalence of nutritional supplement use across different populations because 34 
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such use may place users at increased risk of progressing to use of substances that may 1 
potentially be harmful to health when taken in certain combinations or quantities. 2 
As identified earlier, dancers represent one population where there is limited 3 
knowledge available on nutritional supplement use.  The first study to look at this was 4 
conducted by Stensland and Sobel (1992), who found 60% of US-based dancers reported use 5 
of vitamin or mineral supplements in a relatively small (N = 106) sample of ballet, jazz, and 6 
modern dancers.  Next, in a study of UK dancers involving 1056 dancers from across a range 7 
of formats, Laws (2005) found 63% of dancers reported using supplements, with 56% 8 
reporting use of vitamin supplements, 20% iron supplements, and 20% calcium supplements.  9 
Subsequently, in a study of 127 adolescent ballet dancers, Burckhardt, Wynn, Krieg, Bagutti, 10 
and Faouzi (2011) found 57% of dancers reported taking multi-mineral supplements, vitamin 11 
supplements, or both, whilst 13% reported using calcium supplements.  Finally, Brown and 12 
Wyon (2014) used an online survey to collect data on nutritional supplement use in 334 13 
dancers from 53 countries, finding 50% of dancers reported using nutritional supplements 14 
regularly.  Of those reporting regular use, 60% reported using vitamin C (60%), 67% 15 
multivitamins, 72% caffeine, 21% whey protein and 14% creatine.  Thus, based upon the 16 
fairly limited information available, it would seem prevalence of nutritional supplement use 17 
in dancers is at a comparable level to that seen in sport.  However, more research is needed to 18 
increase the available data, especially given two of these studies are over ten years old and as 19 
such prevalence rates may have changed since then.  20 
Use of medication to support training and performance represents another potential 21 
form of supplementation that is currently understudied in dancers.  Given the severe demands 22 
placed upon dancers that may put them at increased risk of injury (see Allen, Ribbans, Nevill 23 
& Wyon, 2014; Jacobs, Hincapie, & Cassidy, 2012), dancers may at times use pain relief 24 
medications to help with pain management.  Also, given dance represents a discipline that is 25 
thought to promote a focus on aesthetic build and low body weight (see Amorim et al., 2015), 26 
there may be an increased use of medicines (e.g., diuretics, laxatives) that may facilitate 27 
weight loss in dance populations compared to the general population.  Evidence from other 28 
athletic disciplines such as elite sport suggests inappropriate and excessive use of medications 29 
does occur, and may make adverse drug events and interactions with potentially serious 30 
consequences more likely (e.g., Lazic et al., 2011; Tscholl, Feddermann, Junge, & Dvorak, 31 
2008a; Tscholl, Junge, & Dvorak, 2008b).  The work of Sekulic and colleagues also suggests 32 
medicinal substances may be used by dancers. For instance, in one study seven of 25 (i.e., 33 
28%) professional Croatian ballet dancers reported using painkillers often or regularly 34 
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(Sekulic et al., 2010).  In contrast, only 10 of 43 (i.e., 23%) Latin and standard coupled 1 
dancers from Serbia reported any use of painkillers, with only one dancer reporting using 2 
them often (Sekulic, Kostic, Rodek, Damjanovic, & Ostojic, 2009). As such, research is 3 
needed using larger and more diverse samples to increase our knowledge of prevalence of 4 
medicinal supplementation in dance to determine whether some dancers may be putting 5 
themselves at risk through excessive or inappropriate use of such substances. 6 
A third and final understudied form of supplementation in dance relates to the use of 7 
performance enhancing substances.  The severe physical demands associated with dance 8 
mentioned previously may potentially lead to some dancers considering adopting their use.  9 
For instance, this may be driven by attempts to prevent or facilitate recovery from injury.  10 
Alternatively, such use could be driven purely by a desire to improve performance through an 11 
impact on physical attributes such as strength and power.  Given dance is not a sport the use 12 
of such substances by dancers is not controlled under the auspices of WADA as it is in sport.  13 
However, any dancers who do use products such as ephedra, anabolic androgenic steroids, or 14 
beta-blockers to support their training and/or performances are still at increased risk for the 15 
harmful side effects reported by some users (e.g., Andrews, Sudwell, & Sparkes, 2005; 16 
Olrich & Ewing 1999).  Prevalence data from elite sport based upon self-reports has reported 17 
prevalence rates in the region of 5–15% (Laure, 1997).  Within dance, 19% of Latin and 18 
standard coupled dancers from Serbia and 44% of professional Croatian ballet dancers 19 
acknowledged they would use performance enhancers in certain circumstances (Sekulic et al., 20 
2009, 2010).  Although these findings are informative, the small homogeneous samples 21 
involved mean further research that investigates the prevalence of performance enhancing 22 
substance use in dance populations is needed. 23 
Importantly, prevalence for use of certain supplements may be moderated by gender.  24 
For instance, it is possible that differences between male and female dancers regarding the 25 
physical and aesthetic demands placed upon them may lead to disparity in the prevalence of 26 
use for certain supplements.  For instance, strength and associated muscularity are 27 
requirements for male dancers (see Allen et al., 2012), whereas for female dancers high levels 28 
of all round physical fitness and not strength in particular are required, and low body 29 
weight/adiposity are often encouraged (Amorim et al., 2015).  These proposed differences in 30 
physical and aesthetic requirements are supported by research that has shown male dancers to 31 
have a significantly higher BMIs than female dancers (Wyon, Hutchings, Wells, & Neville, 32 
2014).  As such, males may be more likely to use supplements associated with facilitating 33 
strength gains (e.g., protein powders, creatine monohydrate) whereas females may have an 34 
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increased likelihood of using substances thought to assist with weight and body fat loss (e.g., 1 
diuretics, laxatives). 2 
Another potential moderator of prevalence for use of some supplements is 3 
professional status.  Professional dancers are likely to have a higher workload and experience 4 
greater external expectation than amateur dancers, as well as having to perform when not 5 
fully fit due to contractual obligations.  Given this, professional dancers may be more likely 6 
to utilise supplements thought to assist with a high work load and physical conditioning (e.g., 7 
energy drinks, protein supplements), prevent and cope with illness (multivitamins, herbal 8 
remedies), help with pain management (e.g., OTC and prescription painkillers), and facilitate 9 
aesthetic requirements (e.g., diuretics, laxatives).  Support for this contention can be found in 10 
the sport literature, where studies have reported increased supplementation in high 11 
performance athletes compared to those performing at a lower level (Erdman, Fung, & 12 
Reimer, 2006; Giannopoulou, Kostantinos Noutsos, Apostolidis, Bayios & Nassis, 2013). 13 
As well as increasing knowledge of dancers’ use of nutritional, medicinal, and 14 
performance enhancing substances, it is also important to further understanding on potential 15 
sources of information regarding supplement use in dance.  Given the considerable number of 16 
substances available to athletes and ambiguity regarding their relative efficacy, the 17 
importance of obtaining accurate information concerning supplementation has been 18 
highlighted in the literature (e.g., Hoffman, Faigenbaum, Ratamess, Ross, Kang, & 19 
Tenenbaum, 2008; Sundgot-Borgen et al., 2003).  Such research has demonstrated that in 20 
Norwegian elite athletes the coach is the main advisor regarding nutritional supplementation 21 
(Sundgot-Borgen et al., 2003), whereas US adolescent students reported receiving most of 22 
their information from parents and teachers (Hoffman et al., 2008).  In dance, friends and 23 
dance colleagues have been identified as informing dancers’ decisions when selecting which 24 
supplements to take (Brown & Wyon, 2014).  However, Brown and Wyon (2014) only 25 
investigated dietary supplements and not medicinal or performance enhancing substances.  26 
Also, research in sport and exercise has shown that athletes often differentiate between 27 
friends based on whether they train and compete with them when it comes to discussing 28 
issues relating to performance enhancement (see Boardley & Grix, 2014; Boardley, Grix, & 29 
Harkin, 2015).  As such, further research is needed to investigate potential information 30 
sources on supplementation in dance that both takes a more nuanced approach and also 31 
investigates medicinal and performance enhancing substances alongside nutritional 32 
supplements. 33 
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Based upon the reviewed literature, the current study had two aims.  The primary aim 1 
was to investigate the reported prevalence of nutritional, medicinal, and performance 2 
enhancing substance use in dance.  When addressing this aim, we categorised supplements as 3 
a training supplement if was freely available (e.g., multivitamins, OTC painkillers), as a 4 
prescription supplement when a prescription from a doctor was required (e.g., prescription 5 
painkillers, prescription diuretics) and as a performance enhancing supplement if the 6 
substances was prohibited by the International Olympic Committee at the time of data 7 
collection.  Based on potential moderation of supplement use by gender or professional 8 
status, we also examined potential gender and professional status differences for prevalence 9 
of use for all supplements.  The second aim was to examine the amount of importance 10 
dancers placed on potential sources of information regarding which supplements to take, 11 
when to take them, and in what quantity.  12 
Method 13 
Participants 14 
Participants were 371 male (n = 83) and female (n = 286) dancers (two did not 15 
indicate sex) sampled from 24 dance companies across England. Dancers ranged in age from 16 
17.00 to 42.33 years (M = 20.87, SD = 3.84), had danced for an average of 12.12 years (SD = 17 
5.67), practiced/danced for an average of 5.15 hours/day (SD = 2.72), and had been with their 18 
current company for an average of 1.59 years (SD = 2.43). Dance formats included mixed (n 19 
= 138), musical theatre (n = 123), break dancing (n = 24), contemporary (n = 12), jazz (n = 20 
5), and street dance (n = 1), with 68 dancers electing to not indicate their dance format. 21 
Amateur (n = 255), ex-professional (n = 3), and professional (n = 81) dancers were 22 
represented in the sample, with 32 dancers choosing not to indicate their status. 23 
Survey Instrument 24 
The survey consisted of 98 questions focusing on: (a) demographic information (e.g., 25 
age, gender, dance format), (b) training supplement (explicitly defined as “over-the-counter 26 
substances such as non-prescription vitamins, proteins, amino acids, and creatine taken to 27 
help you prepare for performances more effectively or to recover more quickly from 28 
training/injury”) use, (c) prescription supplement (explicitly defined as “substances that you 29 
cannot buy over the counter and require a prescription from a doctor to obtain, taken to help 30 
you prepare for performances more effectively or to recover more quickly from 31 
training/injury”) use, (d) performance enhancing supplement (explicitly defined as 32 
“substances or methods prohibited by the International Olympic Committee but not 33 
controlled in dance and taken to help you prepare for performances more effectively or to 34 
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recover more quickly from training/injury”) use, and (e) importance of potential sources of 1 
information for training, prescription and performance enhancing supplements. 2 
Questions concerning supplement use specifically asked each subject to indicate 3 
which of a series of substances “you use or have used in the past” with response options of 4 
“currently using”, “previously used” or “never used”. Specific substances included in each of 5 
the three sections can be found in the results section.  As such, “currently using” responses 6 
collectively represent a true-point prevalence rate, as they indicate the total number of 7 
identified cases in a specific population at a given point in time (de Hon et al., 2015).  In 8 
contrast, “previously used” responses represent a lifetime prevalence rate, as responses did 9 
not relate to a specific point in time or time period (Harmer, 2010).  Regarding the 10 
importance of potential sources of information for the three categories of supplements, each 11 
subject was asked to indicate how important each potential source was regarding gathering 12 
information on which supplements to take, when to take them, and in what quantity.  Subjects 13 
were provided with 11 choices (i.e., Books/Magazines, Internet, Supplement Supplier, Dance 14 
Master, Physiotherapist, Dance Friend/s, Non-Dance Friend/s, Sibling/s, Strength & 15 
Conditioning Coach, GP/Physician, and Parent/s) and asked to indicate the importance of 16 
each using a scale from 1 (no importance) to 7 (extreme importance). 17 
Procedure 18 
Before the study commenced, ethical approval for it was first obtained from the ethics 19 
committee of the first author’s institution.  Then, dance company leaders were then contacted 20 
by email and/or telephone by a trained research assistant to inform them of the nature of the 21 
study and request the opportunity to invite dancers from their company to participate.  For 22 
leaders who gave their permission, arrangements were made for a convenient opportunity to 23 
visit and speaker with the dancers.  Data collections occurred at dance companies, either prior 24 
to or following a scheduled practice, and were conducted by the research assistant.  Dancers 25 
from each company were addressed as a group, and informed about the nature of the 26 
investigation, what participation involved, and the rights of study participants.  Dancers were 27 
then made aware (verbally and in writing) that nobody other than the research team would 28 
have access to their responses at any stage and that participation was completely anonymous, 29 
before being provided with an opportunity to ask questions.  Those agreeing to participate 30 
were then asked to provide their informed consent by generating and inputting a unique ID 31 
Code, and to retain the ID Code in case they wished to withdraw their data subsequent to 32 
participation (possible for up to three months following participation).  Consenting 33 
participants were then instructed to complete the survey privately and individually. 34 
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Statistical analysis 1 
Percentage current, past, and none use for each type of supplement within each of the 2 
three categories of supplement was first calculated.  Then, to test gender and status effects on 3 
supplement use, binary logistic regressions were conducted for each individual supplement.  4 
In addition, five further logistic regressions were carried out; three included the category of 5 
supplement (i.e., training, prescription, performance-enhancing) as the dependent variable, 6 
and two further analyses investigated potential predictors of supplements groups based on 7 
their association with attempts to Gain Mass and Strength (GMS; i.e., low carb / high protein 8 
powder, amino acids, weight-gain powder, creatine monohydrate), or cause Weight and Fat 9 
Reduction (WFR; i.e., fat burners, high-energy drinks, ephedra, caffeine pills).  For all 10 
regression analyses, past and current use were collapsed into a single “ever used” category. 11 
Regression coefficients (B), their associated standard errors (SE), and odd ratios (OR) are 12 
reported when significance at the p < .05 level was met, along with descriptive percentage 13 
figures (see Table 2).  Following this, descriptive statistics were calculated for participants’ 14 
ratings of importance for the various potential sources of information on which supplements 15 
to take, when to take them, and in what quantity. Based on the results of these analyses, 16 
multiple analysis of variance (MANOVA), followed by between-subjects univariate tests, 17 
were then conducted to test for gender and status differences on the most and least important 18 
sources of information for the three categories of supplement.  SPSS 21.0 was used to 19 
conduct all statistical analyses. 20 
Results 21 
Percentage current, past and none use of supplements 22 
Percentage reported current, previous and none use for all types of training, 23 
prescription and performance enhancing supplements can be found in Table 1.  The reported 24 
use of at least one supplement was reported by 91.9% of the dancers surveyed.  The most 25 
commonly used supplement was multivitamins which were reported to have been used by 26 
72.2% of dancers, closely followed by over-the-counter painkillers which were reported to 27 
have been used by 70.5% of the sample.  The use of training supplements was reported by 28 
90.6% of the dancers, whereas use of prescription and performance enhancing supplements 29 
was reported by 34.0% and 4.0% of the sample, respectively.  The use of supplements that 30 
help GMS was reported by 30.2% of the sample, whereas those associated with WFR was 31 
reported by 65.2% of the dancers. 32 
Nutritional supplement use by gender and status 33 
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To test gender and status effects on supplement use, binary logistic regressions were 1 
employed for each supplement as well as for the five categories (i.e., training, prescription, 2 
performance-enhancing, GMS and WFR) of supplement defined previously; gender and 3 
status were the independent variables, and supplement type/category were the dependent 4 
variables. Non-significant effects (p > 0.05) for gender and status resulted for over-the-5 
counter high energy drinks, caffeine pills, prescription diuretics, corticosteroid or local 6 
anaesthetic injections, bronchodilators, ephedrine stimulants, DMAA stimulants, oral 7 
anabolic androgenic steroids, injectable anabolic androgenic steroids, other anabolic agents, 8 
beta-blockers, peptide hormones (including growth factors & related substances), hormone 9 
and metabolic modulators, blood manipulation, performance enhancing supplements and 10 
WFR supplements.  However, several significant (or approaching significant) effects did 11 
emerge. Betas, standard errors, significance levels and odds ratios for these effects can be 12 
found in Table 2, and descriptive percentage values are presented in Table 3. 13 
Sources of information on supplement use 14 
Means and standard deviations for participants’ ratings of importance for potential 15 
sources of information on the three categories of supplements are reported in Table 4.  These 16 
values indicate that for training supplements physiotherapists were considered the most 17 
important source, for prescription supplements GPs/physicians were rated as most important, 18 
whereas for performance enhancing supplements physiotherapists and GPs/physicians were 19 
held in equally high regard.  Regarding the least important sources of information, non-dance 20 
friends were viewed as the least important source for all three categories of supplement. 21 
Although not directly linked to the study aims, for descriptive purposes MANOVA – 22 
followed by between-subjects univariate tests – were then conducted to test for gender and 23 
status differences on the most and least important sources of information for each category of 24 
supplement.  These analyses revealed a significant multivariate main effect for status (Wilks 25 
λ = 0.95, F (7, 291) = 2.14, p<.05), but not for gender (Wilks λ = 0.96, F (7, 291) = 1.65, 26 
p>.05) or the interaction between gender and status (Wilks λ = 0.97, F (7, 291) = 1.10, 27 
p>.05).  Follow-up between-subject analyses for status revealed amateur dancers (M = 2.39, 28 
SD = 1.59) considered non-dance friends to be a less important source of information on 29 
training supplements than current or ex-professional dancers (M = 2.66, SD = 1.72), F (1, 30 
297) = 4.51, p<.05, ηp
2 
= .02, and that amateur dancers (M = 4.73, SD = 1.93) considered 31 
physiotherapists to be a more important source of information on performance enhancing 32 
supplements than current or ex-professional dancers (M = 4.26, SD = 2.09), F (1, 297) = 4.05, 33 
p<.05, ηp
2 
= .01.  In addition, there was also a marginally significant effect for non-dance 34 
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friends as sources of information on prescription supplements, F (1, 297) = 3.71, p<.06, ηp
2 
= 1 
.01, with amateur athletes (M = 2.08, SD = 1.44) considering them to a less important source 2 
of information than current or ex-professional dancers (M = 2.40, SD = 1.85). 3 
Discussion 4 
 Research in non-dance contexts has demonstrated the importance of research 5 
investigating the prevalence of nutritional (Lazic et al., 2011), medicinal (Tscholl et al., 6 
2008a, 2008b), and performance enhancing (Laure, 1997) supplements.  However, to date 7 
such research in dance is limited and largely constrained to nutritional supplements (e.g., 8 
Brown & Wyon, 2014; Laws, 2005; Sekulic et al., 2009, 2010).  To help address this dearth 9 
in knowledge, the current study had two aims: a) to investigate the reported prevalence of use 10 
– and potential gender/professional status differences – for nutritional, medicinal, and 11 
performance enhancing substance use in dance and b) to examine the importance dancers 12 
place on potential sources of information regarding which supplements to take, when to take 13 
them, and in what quantity.  Overall the study was successful in addressing each of these 14 
aims; over the coming paragraphs we integrate the main findings with the extant literature 15 
and consider their implications. 16 
 Use of at least one supplement was high in the current sample with 91.9% of the 17 
sample reporting use of at least one supplement at some point in their career.  This rate of use 18 
is high in comparison to other studies that have reported values ranging from 49% (Brown & 19 
Wyon, 2014) to 78% (Laws, 2005).  However, it is important to note that in the current study 20 
we examined prevalence for a much broader range of substances, and that this 91.9% 21 
includes previous as well as current use.  Although it is not possible to make direct 22 
comparisons between studies, as a whole the studies that have investigated supplement use in 23 
dance populations demonstrate widespread use of supplementation of some form in this 24 
population. 25 
 Of the freely available supplements – categorised as training supplements – 26 
multivitamins had the highest prevalence, with 36.9% of participants currently using them, 27 
and a further 35.3% reporting using them previously.  This finding corresponds well with the 28 
findings of past studies with dancers that have also reported multivitamin use to be 29 
particularly prevalent (Brown & Wyon, 2014; Stensland & Sobal, 1992).  Sport-based studies 30 
have also reported multivitamins to be one of the most prevalent forms of supplementation 31 
(e.g., Lazic et al., 2011).  As such, it would seem use of multivitamins is fairly widespread 32 
across different athletic populations.  Interestingly, such use is in contrast with research that 33 
has investigated the efficacy of such supplementation (Telford, Catchpole, Deakin, Hahn, & 34 
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Plank, 1992).  More specifically, Telford et al. (1992) found no benefit for athletic 1 
performance when supplementing athletes from four sports with vitamins and minerals over a 2 
seven to eight month period.  Relevant position statements on supplementation also 3 
discourage the use of vitamin and mineral supplements unless athletes are known to have a 4 
dietary deficiency (Rodriguez, DiMarco, & Langley, 2009).  As such, further work is needed 5 
to fully understand why so many dancers take multivitamins, and also to ensure dancers are 6 
appropriately advised on when use of these supplements is appropriate. 7 
Use of OTC painkillers was also reported quite widely, with 27.0% of participants 8 
reporting using them at the time of data collection, and a further 43.5% having previously 9 
used them.  This relatively high prevalence is consistent with work in sport that has estimated 10 
use of painkillers such as non-steroidal anti-inflammatory drugs (NSAIDs) to be considerably 11 
higher in elite athletes than in the general population (Berglund & Sundgot-Borgen, 2001).  12 
This finding supports our contention that the physical demands of dance may dictate that 13 
many dancers frequently experience pain during practice and performance, and feel the need 14 
to use painkillers to help manage this pain.  Given the side effects associated with some OTC 15 
painkillers, such as the gastric irritation associated with use of NSAIDs (Lippi, Franchini, & 16 
Guidi, 2006), this is a worrying finding that clearly warrants further attention in the future. 17 
 The one other supplement that was used quite widely was high energy drinks, with 18 
59.7% of participants reporting their use at some time.  This finding contrasts with that of 19 
Brown and Wyon (2014), who reported just 22% of those who used any supplement 20 
indicating they used energy drinks.  However, Brown and Wyon (2014) sampled from 21 
dancers internationally, with 53 different nations represented.  In contrast, the current study 22 
was conducted solely with UK-based dancers. As such, it is possible that prevalence of 23 
energy drink use is higher in the UK than in other nations.  Further, Brown and Wyon (2014) 24 
didn’t provide respondents with a “previously used” option as we did, with the least frequent 25 
response choice being 1-2 days/week followed by “never”.  As such, it is possible that 26 
dancers who had previously used energy drinks but were not doing so at the time of data 27 
collection chose the “never” option due to the lack of a more appropriate response option.  28 
Certainly, the 17% who reported currently using high energy drinks in the present study 29 
compares more favourably with the 22% of dancers who selected one of the three current use 30 
response options offered by Brown and Wyon (2014).  As such, more research is needed to 31 
determine whether there is a true different in energy drink use between UK dancers and those 32 
from other countries, or whether the apparent differences are due to use of contrasting survey 33 
instruments between the two studies that have investigated this issue. 34 
Supplement Use in Dance 
14 
 
 The second category of supplements investigated currently was that of prescription 1 
supplements.  Of the six supplements in this category, use of prescription painkillers was 2 
most prevalent with 1.9% of dancers reporting their use at the time of data collection, and a 3 
further 18.9% having used them previously.  This finding provides further evidence that the 4 
physical demands of dance may dictate that pain is something that many dancers experience, 5 
and that OTC and prescription painkillers may be utilised as a way to help cope with this 6 
pain.  This is consistent with research that found that as many as 53% of dancers who suspect 7 
an injury report continuing to dance, with 18% of those who continued to dance taking 8 
painkillers in response to the injury (Laws, 2005).  Further, a review of relevant sport 9 
literature identified consistently higher rates of prescription painkiller use by athletes 10 
compared to non-athletes, occurrence of inappropriately high doses, and simultaneous use of 11 
several different painkillers (Alaranta, Alaranta, & Helenius, 2008), suggesting relatively 12 
high rates of prescription painkiller use occurs in other athletic disciplines and not just dance.  13 
Although we didn’t distinguish between different types of painkillers (e.g., NSAIDs, 14 
analgesics-anaesthetics), or the doses that they were taken in, future research investigating 15 
these issues would help elucidate the potential effects of painkiller use in dancers. 16 
 The final category of supplementation investigated was that of performance 17 
enhancing supplements.  The supplements/methods in this category had the lowest prevalence 18 
rates, with ever-use prevalence rates of less than 1% for all such supplements except for beta 19 
blockers, which had been used by 1.6% of dancers at some point.  This is considerably below 20 
the 5-15% of elite athletes who self-reported use of performance enhancing 21 
substances/methods (Laure, 1997) which is particularly interesting when one considers the 22 
controls in place in elite sport to deter doping that are not in place in dance.  Further, the 23 
current findings contrast markedly with those for other unregulated athletic disciplines such 24 
as bodybuilding, where prevalence rates tend to be considerably higher (e.g., Litt & Dodge, 25 
2008).  That a lack of regulation in dance does not appear to lead to increased prevalence can 26 
be explained through a number of possibilities.  For instance, the contrasting aesthetic goals 27 
between dancers and bodybuilders may lead dancers to avoid use of substances that may be 28 
perceived as leading to undesirable muscle gain.  A further possibility is that cultural 29 
differences (e.g., ethical values, social norms) may explain this disparity.  Alternatively, 30 
dancers may not be aware of – or motivated by – the potential performance benefits of using 31 
performance enhancing substances.  However, there is some evidence that a significant 32 
percentage (19-44%) of dancers in certain dance populations would consider using doping 33 
substances if it guaranteed them success (Sekulic et al., 2009, 2010).  Thus, although 34 
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prevalence of performance enhancing supplement use was low in the present study, given the 1 
findings of past research, and the serious health consequences associated with their use, 2 
medical professionals are still encouraged to be watchful for any signs of potential use.  This 3 
is especially the case when one dancer in the current study reported currently or previously 4 
using seven of the nine forms of supplementation in this category. 5 
 Our categorisation of certain substances based upon their prohibition in sport raises 6 
the question of whether use of such substances should be treated similarly in dance.  7 
Obviously there are parallels between sport and dance in terms of athletic requirements (e.g., 8 
strength, power, flexibility) that mean substances outlawed in sport (e.g., anabolic steroids, 9 
ephedrine stimulants) may benefit performance in dance.  However, it is important to 10 
acknowledge that unlike sport, dance is a performing art and performance enhancing 11 
substances banned in sport (e.g., beta-blockers such as propranolol) are used in other art 12 
forms (e.g., music; see Brantigan, Brantigan, & Joseph, 1982) without apparent need for 13 
proscription.  Further, although at the professional level there is undoubtedly competition 14 
between dancers for roles and rank, during performances dancers are not looking to 15 
outperform an opponent as a sportsperson would.  Moreover, dancers are looking to express 16 
themselves through their movements rather than achieve some specified outcome as in sport.  17 
As such, although there are some similarities between the two disciplines, there are also clear 18 
differences between sport and dance that suggest dance as a discipline shouldn’t 19 
automatically adopt a stance on performance enhancing substance use based on that seen in 20 
sport. 21 
An important consideration that may inform any policy decisions in dance relating to 22 
performance enhancing substance use is the potential for detrimental health consequences.  23 
Although many substances banned in sport are therapeutic in origin and can be used in 24 
clinical practice with few or no reported side effects (e.g., Kerr & Congeni, 2007), negative 25 
health effects can occur when supraphysiological doses in excess of those utilised in clinical 26 
practice are employed (Casavant et al., 2007).  Also, the prevalence of diuretic and laxative 27 
use reported in the current study – presumably to help achieve aesthetic ideals (see Amorim 28 
et al., 2015) – suggests some dancers may be prepared to potentially forfeit their health to 29 
achieve success in dance.  More work is clearly needed to determine accurate estimates of 30 
frequency and volume of use for substances that have the potential to be harmful to health.  31 
However, depending on the findings of such work there may be an argument for controlling 32 
use of some substances in dance based on potential health consequences.  If research does 33 
support the need for such measures, careful thought would have to be given on how to 34 
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encourage safe supplementation, especially given the issues with the implementation of anti-1 
doping policy in sport (see Houlihan, 2004). 2 
 Potential gender differences in supplementation were also investigated, with the 3 
relevant analyses demonstrating a higher prevalence of use for a number of supplements (i.e., 4 
low carb/high protein powders, amino acids, weight gain powders, fat burners, creatine 5 
monohydrate, and OTC painkillers) in males compared to females.  With the exception of 6 
OTC painkillers all of these supplements are associated with attempts to increase muscular 7 
appearance and strength, reflected in the significantly higher prevalence for GMS 8 
supplements as a group.   As proposed in the introduction, this difference may be driven by 9 
male dancers’ attempts to gain the strength required to perform male-specific aspects of 10 
performance (e.g., lifting female dance partners) that female dancers do not require (see Allen 11 
et al., 2012).  It was encouraging to find no increased prevalence of WFR supplementation in 12 
females compared to males, suggesting that females were not particularly driven to use 13 
certain supplements in an attempt to achieve aesthetic requirements such as low body weight 14 
and body fat associated with female dancers (Amorim et al., 2015). 15 
 Differences based on professional status were also identified, with current or 16 
previously professional dancers reporting higher prevalence of use for a wide range of 17 
supplements compared to amateur dancers.  Such differences were apparent for a range of 18 
freely available training (e.g., multivitamins, amino acids, OTC diuretics and laxatives) and 19 
prescription (e.g., prescription painkillers, laxatives and decongestants) supplements, as well 20 
as for use of training, prescription, GMS and any supplements when grouped.  This supports 21 
our contention that increases in workload and physical conditioning associated with the 22 
transition to professional status may lead to an increase in supplementation to help cope with 23 
these demands.  The higher prevalence of supplement use in professional dancers compared 24 
to amateur dancers is consistent with research in sport which has indicated increased use of 25 
various dietary supplements at higher levels of competition (Erdman et al., 2006; 26 
Giannopoulou et al., 2013).  However, our findings extend beyond those conducted in elite 27 
sport, as they also indicate greater prevalence of non-dietary supplement use such as 28 
diuretics, laxatives, painkillers and decongestants in current or past professionals compared to 29 
amateurs.  These findings suggest similar research in sport may be warranted, to help 30 
determine whether the differences in dietary supplement use across levels of competition 31 
extend to non-dietary supplements such as those investigated presently.   32 
 A secondary aim of the current study was to investigate dancers’ ratings of 33 
importance for a range of potential information sources regarding supplement use.  Findings 34 
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relating to this aim demonstrated that physiotherapists and GP/physicians were rated as the 1 
two most important sources of information for all three categories of supplement.  This 2 
contrasts with the findings of Brown and Wyon (2014) who reported that use of dietary 3 
supplements was most influenced by friends and colleagues, and that dance teachers were 4 
more influential than doctors or health care professionals.   However, Brown and Wyon asked 5 
just one question relating to what influenced dancers’ decisions when selecting dietary 6 
supplements, which contrasts with the current approach whereby we asked dancers to rate 7 
importance for a range of potential sources of information for use of training, prescription, 8 
and performance enhancing supplements.  This more detailed approach suggests that – for 9 
UK dancers at least – doctors and health care professionals are viewed as important sources 10 
of information for all three categories of supplement.  The distinction made between dance 11 
and non-dance friends (based on the work of Boardley & Grix [2014]) also proved 12 
worthwhile, as dancers reported dance friends to be more important sources of information 13 
for all three categories of supplement.  14 
Limitations and Future Directions 15 
 One important limitation of the current study was the potential for under reporting of 16 
certain forms of supplementation due to the self-report technique employed.  More 17 
specifically, self-report assessment of socially sensitive behaviours such as performance 18 
enhancing supplement use may result in prevalence rates lower than the true rate (de Hon et 19 
al., 2015; Striegel, Ulrich, & Simon, 2010).  This is because people are thought to hold back 20 
when self-reporting attitudes or behaviours that may be perceived as socially undesirable 21 
(e.g., Goldstein, 1960).  As such, although the anonymous nature of data collection and the 22 
fact use of performance enhancing supplements is not controlled in dance may have 23 
weakened this effect in the current study, the actual prevalence of performance enhancing 24 
supplement use may have in reality been higher than that reported by participants.  Future 25 
researchers are encouraged to replicate the current study using alternative approaches such as 26 
the Randomised Response Technique (RRT) which are specifically designed to prevent 27 
socially desirable responding when collecting prevalence data on socially sensitive 28 
behaviours.  Importantly, the RRT has been shown to be a valid approach for the collection of 29 
prevalence data relating to performance enhancing substance use (see de Hon et al., 2015).  A 30 
further limitation is that we only collected data at one point in time, and didn’t assess volume 31 
or frequency of supplement use.  As such, future researchers may wish to investigate whether 32 
the types of supplements used, and frequency and volume of use, change across the 33 
performance season, perhaps in line with changes in workload. 34 
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Conclusion 1 
 The current study provides evidence of widespread use of nutritional and medicinal 2 
supplementation in dancers, but low prevalence for use of performance enhancing substances.  3 
Higher prevalence rates were found for male and professional dancers in comparison to 4 
female and amateur dancers, respectively, for numerous forms of supplementation.  Finally, 5 
physiotherapists and GP/physicians were seen as important sources of information for all 6 
types of supplementation studied.  In sum, although the current study makes an important 7 
contribution to knowledge and understanding on prevalence of supplement use in dance, it 8 
also highlights the need for further research on prevalence rates and potential influences of 9 
supplementation in dance.  By providing evidence of some forms of supplementation that 10 
may have the potential to be harmful to dancers’ health, it also demonstrates a need for dance 11 
as a discipline to consider how dancers may be supported optimally to protect their health.  12 
Such debates have clear relevance to – and may be informed by – contemporary work on 13 
human enhancement more broadly (see Savulescu, ter Meulen, & Kahane, 2011). 14 
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Table 1. Percentage current, previous and none use of supplements (N = 371) 1 
Training Supplements 
Supplement Current Previous Never 
Multivitamins 36.9 35.3 27.8 
Low carb / high protein powder 13.0 14.1 72.9 
Amino acids 2.5 4.9 92.6 
Weight gain powder 1.6 3.0 95.4 
Fat burners 3.2 8.4 88.4 
High energy drinks 17.0 42.7 40.3 
Caffeine pills 1.1 13.5 85.4 
Creatine 1.1 2.2 96.8 
Over the counter painkillers 27.0 43.5 29.5 
Over the counter diuretics 1.1 3.8 95.1 
Over the counter laxatives 1.9 6.8 91.4 
Herbal remedies 10.8 19.7 69.5 
Prescription Supplements 
Supplement Current Previous Never 
Prescription painkillers 1.9 18.9 79.2 
Prescription diuretics  0.8 0.0 99.2 
Prescription laxatives 0.5 3.2 96.2 
Corticosteroid or local anaesthetic injections 0.3 10.5 89.2 
Prescription decongestants 1.1 5.4 93.5 
Bronchodilators 4.1 4.9 91.1 
Performance Enhancing Supplements 
Supplement Current Previous Never 
Ephedrine stimulants 0.5 0.3 99.2 
DMAA stimulants 0.0 0.3 99.7 
Oral anabolic androgenic steroids 0.0 0.3 99.7 
Injectable anabolic androgenic steroids 0.3 0.0 99.7 
Other anabolic agents 0.0 0.3 99.7 
Beta blockers 0.5 1.1 98.4 
Peptide Hormones, growth factors, and related 0.0 0.5 99.5 
Hormone and metabolic modulators 0.5 0.3 99.2 
Blood manipulation 0.3 0.5 99.2 
 2 
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Table 2. Betas, standard errors, significance levels, and odds ratios for significant or marginally significant logistic regressions (N = 371) 1 
Supplement type / category 
Gender Status 
β SE p OR β SE p OR 
Multivitamins - - - - -.079 0.32 <.05 1:0.45 
Low carb/high protein 1.11 0.28 <.001 1:3.04 -0.83 0.28 <.01 1:0.44 
Amino acids 0.81 0.45 <.08 1:2.24 -1.75 0.45 <.001 1:0.17 
Weight gain powder 2.28 0.60 <.001 1:9.80 - - - - 
Fat burners - - - - -0.90 0.36 <.05 1:0.41 
Creatine monohydrate 2.31 0.70 <.01 1:10.04 -2.27 0.70 <.01 1:0.10 
Over-the-counter painkillers 0.58 0.31 <.06 1:1.79 - - - - 
Over-the-counter diuretics - - - - -0.95 0.50 <0.06 1:0.39 
Over-the-counter laxatives - - - - -1.30 0.41 <.01 1:0.27 
Herbal remedies - - - - -0.95 0.27 <.001 1:0.39 
Prescription painkillers - - - - -0.87 0.30 <.01 1:0.42 
Prescription laxatives - - - - -1.41 0.62 <.05 1:0.25 
Prescription decongestants - - - - -0.91 0.44 <.05 1:0.40 
Training supplements - - - - -1.68 0.74 <.05 1:0.19 
Prescription supplements - - - - -0.91 0.26 <.01 1:0.40 
Any supplement - - - - -2.24 1.03 <.05 1:0.11 
GMS supplements 1.04 0.28 <.001 1:2.83 -1.05 0.27 <.001 1:0.35 
Note. - indicates no significant effect of gender/status on reported use of this supplement type or category. GMS = Gain Mass and Strength. 2 
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Table 3. Percentage figures for significant or marginally significant logistic regressions (N = 371) 1 
Supplement type/category 
Gender Status 
Male Female Never Professional Ever Professional 
% Never 
Used 
% Ever 
Used 
% Never 
Used 
% Ever 
Used 
% Never 
Used 
% Ever 
Used 
% Never 
Used 
% Ever 
Used 
Multivitamins - - - - 32.9 67.1 17.9 82.1 
Low carb / high protein powder 54.2 45.8 78.2 21.8 78.0 22.0 60.7 39.3 
Amino acids 87.8 12.2 94.0 6.0 96.4 3.6 82.1 17.9 
Weight gain powder 85.5 14.5 98.2 1.8 - - - - 
Fat burners - - - - 90.6 9.4 81.0 19.0 
Creatine monohydrate 89.2 10.8 98.9 1.1 98.8 1.2 89.3 10.7 
Over-the-counter painkillers 21.7 78.3 31.6 68.4 - - - - 
Over-the-counter diuretics - - - - 96.0 4.0 90.4 9.6 
Over-the-counter laxatives - - - - 94.5 5.5 83.3 16.7 
Herbal remedies - - - - 74.4 25.6 54.8 45.2 
Prescription painkillers - - - - 84.3 15.7 70.2 29.8 
Prescription laxatives - - - - 98.0 2.0 92.9 7.1 
Prescription decongestants - - - - 94.5 5.5 88.1 11.9 
Training supplements - - - - 12.2 87.8 2.4 97.6 
Prescription supplements - - - - 71.8 28.2 52.4 47.6 
Any supplement - - - - 10.6 89.4 1.2 98.8 
GMS supplements 51.8 48.2 74.8 25.2 76.5 23.5 53.6 46.4 
Note. - indicates no significant effect of gender/status on reported use of this supplement. GMS = Gain Mass and Strength. 2 
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Table 4. Descriptive statistics for ratings of importance on potential information sources regarding supplement use (N = 371) 1 
 
Training 
Supplements 
Prescription 
Supplements 
Performance Enhancing 
Supplements 
Potential Source of Information M SD M SD M SD 
Books/Magazines 3.49 1.76 2.91 1.81 3.16 1.88 
Internet 4.22 1.97 3.42 1.98 3.58 1.97 
Supplement Supplier 3.81 2.06 3.67 2.05 3.67 2.04 
Dance Master 4.77 1.92 4.14 1.97 4.54 1.98 
Physiotherapist 5.33 1.73 4.71 1.98 4.67 1.93 
Dance Friend/s 4.00 1.81 3.19 1.88 3.64 1.91 
Non-Dance Friend/s 2.60 1.76 2.27 1.63 2.30 1.60 
Sibling/s 2.82 1.84 2.42 1.72 2.37 1.62 
Strength & Conditioning Coach 4.95 1.78 4.38 1.92 4.47 1.93 
GP/Physician 5.04 1.78 5.03 2.02 4.66 2.00 
Parent/s 3.80 2.03 3.34 2.05 3.12 2.00 
Note. Possible scores ranged from 1 (No Importance) to 7 (Extreme Importance), and the full range of possible responses was provided for all 2 
source/supplement combinations. Emboldened values represent the most importance source, whereas underlined values represent the least 3 
important source. 4 
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